Table of Content

1 Alternative to Antibiotics Market Overview
1.1 Alternative to Antibiotics Product Overview
1.2 Alternative to Antibiotics Market Segment by Type
1.2.1 Antimicrobial Proteins
1.2.2 Bacteriophages
1.2.3 Probiotics
1.2.4 Other
1.3 Global Alternative to Antibiotics Market Size by Type
1.3.1 Global Alternative to Antibiotics Market Size Overview by Type (2024-2034)
1.3.2 Global Alternative to Antibiotics Historic Market Size Review by Type (2024-2024)
1.3.3 Global Alternative to Antibiotics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Alternative to Antibiotics Sales Breakdown by Type (2024-2024)
1.4.2 Europe Alternative to Antibiotics Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Alternative to Antibiotics Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Type (2024-2024)
2 Global Alternative to Antibiotics Market Competition by Company
2.1 Global Top Players by Alternative to Antibiotics Sales (2024-2024)
2.2 Global Top Players by Alternative to Antibiotics Revenue (2024-2024)
2.3 Global Top Players by Alternative to Antibiotics Price (2024-2024)
2.4 Global Top Manufacturers Alternative to Antibiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Alternative to Antibiotics Market Competitive Situation and Trends
2.5.1 Alternative to Antibiotics Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Alternative to Antibiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alternative to Antibiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Alternative to Antibiotics Market
2.8 Key Manufacturers Alternative to Antibiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Alternative to Antibiotics Status and Outlook by Region
3.1 Global Alternative to Antibiotics Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Alternative to Antibiotics Historic Market Size by Region
3.2.1 Global Alternative to Antibiotics Sales in Volume by Region (2024-2024)
3.2.2 Global Alternative to Antibiotics Sales in Value by Region (2024-2024)
3.2.3 Global Alternative to Antibiotics Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Alternative to Antibiotics Forecasted Market Size by Region
3.3.1 Global Alternative to Antibiotics Sales in Volume by Region (2024-2034)
3.3.2 Global Alternative to Antibiotics Sales in Value by Region (2024-2034)
3.3.3 Global Alternative to Antibiotics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Alternative to Antibiotics by Application
4.1 Alternative to Antibiotics Market Segment by Application
4.1.1 Food & Beverage
4.1.2 Drugs
4.1.3 Dietary Supplements
4.2 Global Alternative to Antibiotics Market Size by Application
4.2.1 Global Alternative to Antibiotics Market Size Overview by Application (2024-2034)
4.2.2 Global Alternative to Antibiotics Historic Market Size Review by Application (2024-2024)
4.2.3 Global Alternative to Antibiotics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Alternative to Antibiotics Sales Breakdown by Application (2024-2024)
4.3.2 Europe Alternative to Antibiotics Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Alternative to Antibiotics Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Application (2024-2024)
5 North America Alternative to Antibiotics by Country
5.1 North America Alternative to Antibiotics Historic Market Size by Country
5.1.1 North America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Alternative to Antibiotics Sales in Volume by Country (2024-2024)
5.1.3 North America Alternative to Antibiotics Sales in Value by Country (2024-2024)
5.2 North America Alternative to Antibiotics Forecasted Market Size by Country
5.2.1 North America Alternative to Antibiotics Sales in Volume by Country (2024-2034)
5.2.2 North America Alternative to Antibiotics Sales in Value by Country (2024-2034)
6 Europe Alternative to Antibiotics by Country
6.1 Europe Alternative to Antibiotics Historic Market Size by Country
6.1.1 Europe Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Alternative to Antibiotics Sales in Volume by Country (2024-2024)
6.1.3 Europe Alternative to Antibiotics Sales in Value by Country (2024-2024)
6.2 Europe Alternative to Antibiotics Forecasted Market Size by Country
6.2.1 Europe Alternative to Antibiotics Sales in Volume by Country (2024-2034)
6.2.2 Europe Alternative to Antibiotics Sales in Value by Country (2024-2034)
7 Asia-Pacific Alternative to Antibiotics by Region
7.1 Asia-Pacific Alternative to Antibiotics Historic Market Size by Region
7.1.1 Asia-Pacific Alternative to Antibiotics Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Alternative to Antibiotics Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Alternative to Antibiotics Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Alternative to Antibiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Alternative to Antibiotics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Alternative to Antibiotics Sales in Value by Region (2024-2034)
8 Latin America Alternative to Antibiotics by Country
8.1 Latin America Alternative to Antibiotics Historic Market Size by Country
8.1.1 Latin America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Alternative to Antibiotics Sales in Volume by Country (2024-2024)
8.1.3 Latin America Alternative to Antibiotics Sales in Value by Country (2024-2024)
8.2 Latin America Alternative to Antibiotics Forecasted Market Size by Country
8.2.1 Latin America Alternative to Antibiotics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Alternative to Antibiotics Sales in Value by Country (2024-2034)
9 Middle East and Africa Alternative to Antibiotics by Country
9.1 Middle East and Africa Alternative to Antibiotics Historic Market Size by Country
9.1.1 Middle East and Africa Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Alternative to Antibiotics Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Alternative to Antibiotics Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Alternative to Antibiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Alternative to Antibiotics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Alternative to Antibiotics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 DSM
10.1.1 DSM Company Information
10.1.2 DSM Introduction and Business Overview
10.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.1.4 DSM Alternative to Antibiotics Products Offered
10.1.5 DSM Recent Development
10.2 DuPont(Danisco)
10.2.1 DuPont(Danisco) Company Information
10.2.2 DuPont(Danisco) Introduction and Business Overview
10.2.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.2.4 DuPont(Danisco) Alternative to Antibiotics Products Offered
10.2.5 DuPont(Danisco) Recent Development
10.3 Chr. Hansen
10.3.1 Chr. Hansen Company Information
10.3.2 Chr. Hansen Introduction and Business Overview
10.3.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Chr. Hansen Alternative to Antibiotics Products Offered
10.3.5 Chr. Hansen Recent Development
10.4 Lallemand
10.4.1 Lallemand Company Information
10.4.2 Lallemand Introduction and Business Overview
10.4.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Lallemand Alternative to Antibiotics Products Offered
10.4.5 Lallemand Recent Development
10.5 China-Biotics
10.5.1 China-Biotics Company Information
10.5.2 China-Biotics Introduction and Business Overview
10.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.5.4 China-Biotics Alternative to Antibiotics Products Offered
10.5.5 China-Biotics Recent Development
10.6 Nestle
10.6.1 Nestle Company Information
10.6.2 Nestle Introduction and Business Overview
10.6.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Nestle Alternative to Antibiotics Products Offered
10.6.5 Nestle Recent Development
10.7 Danone
10.7.1 Danone Company Information
10.7.2 Danone Introduction and Business Overview
10.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Danone Alternative to Antibiotics Products Offered
10.7.5 Danone Recent Development
10.8 Probi
10.8.1 Probi Company Information
10.8.2 Probi Introduction and Business Overview
10.8.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Probi Alternative to Antibiotics Products Offered
10.8.5 Probi Recent Development
10.9 BioGaia
10.9.1 BioGaia Company Information
10.9.2 BioGaia Introduction and Business Overview
10.9.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.9.4 BioGaia Alternative to Antibiotics Products Offered
10.9.5 BioGaia Recent Development
10.10 Yakult
10.10.1 Yakult Company Information
10.10.2 Yakult Introduction and Business Overview
10.10.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Yakult Alternative to Antibiotics Products Offered
10.10.5 Yakult Recent Development
10.11 Novozymes
10.11.1 Novozymes Company Information
10.11.2 Novozymes Introduction and Business Overview
10.11.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Novozymes Alternative to Antibiotics Products Offered
10.11.5 Novozymes Recent Development
10.12 Valio
10.12.1 Valio Company Information
10.12.2 Valio Introduction and Business Overview
10.12.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Valio Alternative to Antibiotics Products Offered
10.12.5 Valio Recent Development
10.13 Glory Biotech
10.13.1 Glory Biotech Company Information
10.13.2 Glory Biotech Introduction and Business Overview
10.13.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Glory Biotech Alternative to Antibiotics Products Offered
10.13.5 Glory Biotech Recent Development
10.14 Ganeden
10.14.1 Ganeden Company Information
10.14.2 Ganeden Introduction and Business Overview
10.14.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Ganeden Alternative to Antibiotics Products Offered
10.14.5 Ganeden Recent Development
10.15 Morinaga Milk Industry
10.15.1 Morinaga Milk Industry Company Information
10.15.2 Morinaga Milk Industry Introduction and Business Overview
10.15.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Morinaga Milk Industry Alternative to Antibiotics Products Offered
10.15.5 Morinaga Milk Industry Recent Development
10.16 Sabinsa
10.16.1 Sabinsa Company Information
10.16.2 Sabinsa Introduction and Business Overview
10.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Sabinsa Alternative to Antibiotics Products Offered
10.16.5 Sabinsa Recent Development
10.17 Greentech
10.17.1 Greentech Company Information
10.17.2 Greentech Introduction and Business Overview
10.17.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Greentech Alternative to Antibiotics Products Offered
10.17.5 Greentech Recent Development
10.18 Bioriginal
10.18.1 Bioriginal Company Information
10.18.2 Bioriginal Introduction and Business Overview
10.18.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Bioriginal Alternative to Antibiotics Products Offered
10.18.5 Bioriginal Recent Development
10.19 Biosearch Life
10.19.1 Biosearch Life Company Information
10.19.2 Biosearch Life Introduction and Business Overview
10.19.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Biosearch Life Alternative to Antibiotics Products Offered
10.19.5 Biosearch Life Recent Development
10.20 UAS Laboratories
10.20.1 UAS Laboratories Company Information
10.20.2 UAS Laboratories Introduction and Business Overview
10.20.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.20.4 UAS Laboratories Alternative to Antibiotics Products Offered
10.20.5 UAS Laboratories Recent Development
10.21 Synbiotech
10.21.1 Synbiotech Company Information
10.21.2 Synbiotech Introduction and Business Overview
10.21.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.21.4 Synbiotech Alternative to Antibiotics Products Offered
10.21.5 Synbiotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Alternative to Antibiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Alternative to Antibiotics Industrial Chain Analysis
11.4 Alternative to Antibiotics Market Dynamics
11.4.1 Alternative to Antibiotics Industry Trends
11.4.2 Alternative to Antibiotics Market Drivers
11.4.3 Alternative to Antibiotics Market Challenges
11.4.4 Alternative to Antibiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Alternative to Antibiotics Distributors
12.3 Alternative to Antibiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antimicrobial Proteins
Table 2. Major Company of Bacteriophages
Table 3. Major Company of Probiotics
Table 4. Major Company of Other
Table 5. Global Alternative to Antibiotics Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Alternative to Antibiotics Sales by Type (2024-2024) & (K Units)
Table 7. Global Alternative to Antibiotics Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Alternative to Antibiotics Sales by Type (2024-2024) & (US& Million)
Table 9. Global Alternative to Antibiotics Market Share in Value by Type (2024-2024)
Table 10. Global Alternative to Antibiotics Price by Type (2024-2024) & (USD/Unit)
Table 11. Global Alternative to Antibiotics Sales by Type (2024-2034) & (K Units)
Table 12. Global Alternative to Antibiotics Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Alternative to Antibiotics Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Alternative to Antibiotics Sales Market Share in Value by Type (2024-2034)
Table 15. Global Alternative to Antibiotics Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Alternative to Antibiotics Sales by Type (2024-2024) & (K Units)
Table 17. North America Alternative to Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Alternative to Antibiotics Sales (K Units) by Type (2024-2024)
Table 19. Europe Alternative to Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Alternative to Antibiotics Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Alternative to Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Alternative to Antibiotics Sales (K Units) by Type (2024-2024)
Table 23. Latin America Alternative to Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Alternative to Antibiotics Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Alternative to Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Alternative to Antibiotics Sales by Company (2024-2024) & (K Units)
Table 27. Global Alternative to Antibiotics Sales Share by Company (2024-2024)
Table 28. Global Alternative to Antibiotics Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Alternative to Antibiotics Revenue Share by Company (2024-2024)
Table 30. Global Market Alternative to Antibiotics Price by Company (2024-2024) & (USD/Unit)
Table 31. Global Alternative to Antibiotics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Alternative to Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alternative to Antibiotics as of 2022)
Table 34. Date of Key Manufacturers Enter into Alternative to Antibiotics Market
Table 35. Key Manufacturers Alternative to Antibiotics Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Alternative to Antibiotics Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Alternative to Antibiotics Sales by Region (2024-2024) & (K Units)
Table 39. Global Alternative to Antibiotics Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Alternative to Antibiotics Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Alternative to Antibiotics Sales Market Share in Value by Region (2024-2024)
Table 42. Global Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global Alternative to Antibiotics Sales by Region (2024-2034) & (K Units)
Table 44. Global Alternative to Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Alternative to Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Alternative to Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 47. Global Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Alternative to Antibiotics Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Alternative to Antibiotics Sales by Application (2024-2024) & (K Units)
Table 50. Global Alternative to Antibiotics Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Alternative to Antibiotics Sales Market Share in Value by Application (2024-2024)
Table 53. Global Alternative to Antibiotics Price by Application (2024-2024) & (USD/Unit)
Table 54. Global Alternative to Antibiotics Sales by Application (2024-2034) & (K Units)
Table 55. Global Alternative to Antibiotics Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Alternative to Antibiotics Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Alternative to Antibiotics Sales Market Share in Value by Application (2024-2034)
Table 58. Global Alternative to Antibiotics Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Alternative to Antibiotics Sales by Application (2024-2024) (K Units)
Table 60. North America Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Alternative to Antibiotics Sales by Application (2024-2024) (K Units)
Table 62. Europe Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Alternative to Antibiotics Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Alternative to Antibiotics Sales by Application (2024-2024) (K Units)
Table 66. Latin America Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Alternative to Antibiotics Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Alternative to Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Alternative to Antibiotics Sales by Country (2024-2024) & (K Units)
Table 70. North America Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Alternative to Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Alternative to Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 73. North America Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 74. North America Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Alternative to Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Alternative to Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Alternative to Antibiotics Sales by Country (2024-2024) & (K Units)
Table 78. Europe Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Alternative to Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Alternative to Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 82. Europe Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Alternative to Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Alternative to Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Alternative to Antibiotics Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Alternative to Antibiotics Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Alternative to Antibiotics Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Alternative to Antibiotics Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Alternative to Antibiotics Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Alternative to Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Alternative to Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Alternative to Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Alternative to Antibiotics Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Alternative to Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Alternative to Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Alternative to Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Alternative to Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Alternative to Antibiotics Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Alternative to Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Alternative to Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Alternative to Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Alternative to Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Alternative to Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 109. DSM Company Information
Table 110. DSM Introduction and Business Overview
Table 111. DSM Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. DSM Alternative to Antibiotics Product
Table 113. DSM Recent Development
Table 114. DuPont(Danisco) Company Information
Table 115. DuPont(Danisco) Introduction and Business Overview
Table 116. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. DuPont(Danisco) Alternative to Antibiotics Product
Table 118. DuPont(Danisco) Recent Development
Table 119. Chr. Hansen Company Information
Table 120. Chr. Hansen Introduction and Business Overview
Table 121. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. Chr. Hansen Alternative to Antibiotics Product
Table 123. Chr. Hansen Recent Development
Table 124. Lallemand Company Information
Table 125. Lallemand Introduction and Business Overview
Table 126. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Lallemand Alternative to Antibiotics Product
Table 128. Lallemand Recent Development
Table 129. China-Biotics Company Information
Table 130. China-Biotics Introduction and Business Overview
Table 131. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. China-Biotics Alternative to Antibiotics Product
Table 133. China-Biotics Recent Development
Table 134. Nestle Company Information
Table 135. Nestle Introduction and Business Overview
Table 136. Nestle Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. Nestle Alternative to Antibiotics Product
Table 138. Nestle Recent Development
Table 139. Danone Company Information
Table 140. Danone Introduction and Business Overview
Table 141. Danone Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. Danone Alternative to Antibiotics Product
Table 143. Danone Recent Development
Table 144. Probi Company Information
Table 145. Probi Introduction and Business Overview
Table 146. Probi Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 147. Probi Alternative to Antibiotics Product
Table 148. Probi Recent Development
Table 149. BioGaia Company Information
Table 150. BioGaia Introduction and Business Overview
Table 151. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 152. BioGaia Alternative to Antibiotics Product
Table 153. BioGaia Recent Development
Table 154. Yakult Company Information
Table 155. Yakult Introduction and Business Overview
Table 156. Yakult Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 157. Yakult Alternative to Antibiotics Product
Table 158. Yakult Recent Development
Table 159. Novozymes Company Information
Table 160. Novozymes Introduction and Business Overview
Table 161. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 162. Novozymes Alternative to Antibiotics Product
Table 163. Novozymes Recent Development
Table 164. Valio Company Information
Table 165. Valio Introduction and Business Overview
Table 166. Valio Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 167. Valio Alternative to Antibiotics Product
Table 168. Valio Recent Development
Table 169. Glory Biotech Company Information
Table 170. Glory Biotech Introduction and Business Overview
Table 171. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 172. Glory Biotech Alternative to Antibiotics Product
Table 173. Glory Biotech Recent Development
Table 174. Ganeden Company Information
Table 175. Ganeden Introduction and Business Overview
Table 176. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 177. Ganeden Alternative to Antibiotics Product
Table 178. Ganeden Recent Development
Table 179. Morinaga Milk Industry Company Information
Table 180. Morinaga Milk Industry Introduction and Business Overview
Table 181. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 182. Morinaga Milk Industry Alternative to Antibiotics Product
Table 183. Morinaga Milk Industry Recent Development
Table 184. Sabinsa Company Information
Table 185. Sabinsa Introduction and Business Overview
Table 186. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 187. Sabinsa Alternative to Antibiotics Product
Table 188. Sabinsa Recent Development
Table 189. Greentech Company Information
Table 190. Greentech Introduction and Business Overview
Table 191. Greentech Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 192. Greentech Alternative to Antibiotics Product
Table 193. Greentech Recent Development
Table 194. Bioriginal Company Information
Table 195. Bioriginal Introduction and Business Overview
Table 196. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 197. Bioriginal Alternative to Antibiotics Product
Table 198. Bioriginal Recent Development
Table 199. Biosearch Life Company Information
Table 200. Biosearch Life Introduction and Business Overview
Table 201. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 202. Biosearch Life Alternative to Antibiotics Product
Table 203. Biosearch Life Recent Development
Table 204. UAS Laboratories Company Information
Table 205. UAS Laboratories Introduction and Business Overview
Table 206. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 207. UAS Laboratories Alternative to Antibiotics Product
Table 208. UAS Laboratories Recent Development
Table 209. Synbiotech Company Information
Table 210. Synbiotech Introduction and Business Overview
Table 211. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 212. Synbiotech Alternative to Antibiotics Product
Table 213. Synbiotech Recent Development
Table 214. Key Raw Materials Lists
Table 215. Raw Materials Key Suppliers Lists
Table 216. Alternative to Antibiotics Market Trends
Table 217. Alternative to Antibiotics Market Drivers
Table 218. Alternative to Antibiotics Market Challenges
Table 219. Alternative to Antibiotics Market Restraints
Table 220. Alternative to Antibiotics Distributors List
Table 221. Alternative to Antibiotics Downstream Customers
Table 222. Research Programs/Design for This Report
Table 223. Key Data Information from Secondary Sources
Table 224. Key Data Information from Primary Sources
List of Figures
Figure 1. Alternative to Antibiotics Product Picture
Figure 2. Global Alternative to Antibiotics Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Alternative to Antibiotics Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Alternative to Antibiotics Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Antimicrobial Proteins
Figure 6. Global Antimicrobial Proteins Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Bacteriophages
Figure 8. Global Bacteriophages Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Probiotics
Figure 10. Global Probiotics Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Alternative to Antibiotics Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Alternative to Antibiotics Sales Market Share by Type in 2022 & 2034
Figure 15. North America Alternative to Antibiotics Sales Market Share in Volume by Type in 2022
Figure 16. North America Alternative to Antibiotics Sales Market Share in Value by Type in 2022
Figure 17. Europe Alternative to Antibiotics Sales Market Share in Volume by Type in 2022
Figure 18. Europe Alternative to Antibiotics Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Alternative to Antibiotics Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Alternative to Antibiotics Sales Market Share in Value by Type in 2022
Figure 21. Latin America Alternative to Antibiotics Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Alternative to Antibiotics Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Alternative to Antibiotics Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Alternative to Antibiotics Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Alternative to Antibiotics Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Alternative to Antibiotics Revenue in 2022
Figure 27. Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Food & Beverage
Figure 29. Global Food & Beverage Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Drugs
Figure 31. Global Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Dietary Supplements
Figure 33. Global Dietary Supplements Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Alternative to Antibiotics Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Alternative to Antibiotics Sales Market Share by Application in 2022 & 2034
Figure 36. North America Alternative to Antibiotics Sales Market Share in Volume by Application in 2022
Figure 37. North America Alternative to Antibiotics Sales Market Share in Value by Application in 2022
Figure 38. Europe Alternative to Antibiotics Sales Market Share in Volume by Application in 2022
Figure 39. Europe Alternative to Antibiotics Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Alternative to Antibiotics Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Alternative to Antibiotics Sales Market Share in Value by Application in 2022
Figure 42. Latin America Alternative to Antibiotics Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Alternative to Antibiotics Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Alternative to Antibiotics Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Alternative to Antibiotics Manufacturing Cost Structure
Figure 47. Alternative to Antibiotics Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed